Jewish American Heritage Month

Posted By richards on April 14, 2016

Test

Gene(s)

Further Information

BRCA1 and BRCA2 Sequencing and Del/DupAnalysis

BRCA1, BRCA2

BRCA1 and BRCA2 Ashkenazi Founder Panel

BRCA1/ BRCA2 Targeted Pathogenic Variant Analysis (BRCA1 c.68_69delAG [also known as 185delAGor 187delAG], c.5266dupC [also known as 5382insC or 5385insC] and BRCA2c.5946delT [also knownas 6174delT])

Comprehensive Cancer Panel (32 Genes)

APC, ATM, AXIN2, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM,FANCC, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SCG5/GREM1, SMAD4, STK11, TP53, VHL, XRCC2

Breast Cancer High Risk Panel

(6 Genes)

Breast Cancer High Risk Panel and PALB2

(7 Genes)

Breast Cancer High/Moderate Risk Panel

(9 Genes)

ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, STK11, TP53

Lynch/Colorectal High Risk Panel (7 Genes)

APC, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2

MSH2 Exon 1-7 Inversion Analysis

MSH2

Familial Cutaneous Malignant Melanoma

(2 Genes)

CDKN2A, CDK4

Pancreatic Cancer Panel (16Genes)

APC, ATM, BRCA1, BRCA2, CDK4, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2,PMS2, STK11, TP53, VHL, XRCC2

Pediatric Tumor Panel (27 genes)

ALK, APC, CDC73, DICER1, EPCAM, MEN1, MLH1, MSH2, MSH6, NF1, NF2, PHOX2B, PMS2, PRKAR1A, PTCH1, PTEN, RB1, RET, SMARCA4, SMARCB1, STK11, SUFU, TP53, TSC1, TSC2, VHL, WT1

PGL/PCC (Paraganglioma/Pheochromocytoma) Panel (12 Genes)

FH, MAX, MEN1, NF1, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, VHL

Renal Cancer Panel(18 Genes)

Rest of Comprehensive Cancer Panel

(if subpanel negative)

Continued here:
Oncology Genetics - Genetic Testing Company | The DNA ...

Category: Ashkenazi
Tags: